One of Pfizer Inc. (NYSE:PFE)'s best selling drugs is Viagra, which is used to treat erectile dysfunction. That particular ailment carries material social stigma and the pills, which are still under patent protection for many more years, can be ...

Pfizer Inc. announced today the discontinuation of a Phase 3 randomized, open-label, two-arm study (B1931008) evaluating the safety and efficacy of the investigational compound inotuzumab ozogamicin in patients with relapsed or refractory CD22+ ...

Zoetis Inc. (NYSE: ZTS) announced it intends to file a Registration Statement on Form S-4 with the Securities and Exchange Commission (SEC) today in connection with the proposed exchange offer announced by Pfizer Inc. (NYSE: PFE). As part of the offer, ...

KALAMAZOO, MI - Pfizer Inc. is now delivering its erectile dysfunction Viagra tablets to patients who order it online to fight counterfeit product sales.

3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad We dread some checkups. Some people even put them off. If you own Pfizer Inc. (NYSE:PFE) stock, though, there's no need for dread or delay. Here is your painless and free stock ...

Pfizer Inc. (NYSE:PFE) is also getting in the action with its phase 1b trial of CVX-060 in combination Inlyta, with its FDA-approved drug.

Editor's Note: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Petroleo Brasileiro Petrobras SA (NYSE:PBR), American Express Company (NYSE:AXP).

Advanced Investment Partners also holds shares of pharmaceutical giant Pfizer Inc. (NYSE:PFE), buying an additional 325,968 shares during the quarter, bringing the fund's total holding to 566,138, as reported in the 13F.

3 Drug Launches You Need to Know in 2013: Pfizer, NPS Pharma, Ariad Pfizer Inc. (NYSE:PFE) stock has been a boon for growth investors over the past year.

Pfizer Inc. (NYSE:PFE) markets Oxecta, a narcotic pain medicine that uses the Aversion technology. However, the company can't make claims of abuse deterrence because of FDA rules barring such language without extensive studies showing reduction in ...